The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...

The risk and incidence of cancer among people under 50 is also on the rise, according to American Cancer Society.

Cancer rates for young women are sharply rising, with women under 50 more likely to develop cancer than their male ...

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...